Gilead Sciences Inc at SVB Leerink Global Healthcare (Virtual) Transcript
Great. So good afternoon, everyone, at least everyone that's on the East Coast. It's my pleasure to welcome Gilead's Chief Medical Officer, Dr. Merdad Parsey. Obviously, many of you know him. But just to remind you, if you don't, he's responsible for overseeing the company's global clinical development and medical affairs organizations. He supervises all the clinical trials and development activities. And along with the leadership team, he works to advance clinical development strategies and programs with the goal of changing the trajectory of disease and transforming care for patients today and tomorrow.
Merdad originally joined Gilead in 2019 from Genentech, where he had served as President of Early Clinical Development. So we're fortunate to have him with us today. Thank you for taking the time, Merdad.
Questions & Answers
I thought that it would be helpful to maybe start at a very high level. And since you do interact with
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
